PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Hanneke van der Woude

Medicines Evaluation Board

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines1

Latest

Everything in the corpus, newest first.

SEP 7, 2026 · JOURNAL ARTICLE

Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset

Clinical Pharmacology & Therapeutics

This is a consensus-derived core dataset specification developed through systematic literature review and multi-stakeholder expert meetings to standardize real-world data collection for NSCLC drug evaluation.

Expert GuidanceDoranne Hilarius Cornelis Boersma Lung Cancer Treatments and Mutations

Reported

General patient characteristics v…6

Disease-specific factor variables19

Treatment detail variables22

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support